Location Mismatch! The current page information is for Europe

It looks like you are in North America YesNo

Latest News

UK MoD selects Celox Rapid Haemostatic Gauze for all branches of the UK Military

Thursday, January 11th, 2018

After extensive evaluation the UK Ministry of Defence (MoD) has selected Celox Rapid as its haemostat of choice.

Celox Rapid Gauze selected by UK MOD

UK MOD Selects Celox Rapid as haemostatic of choice

The Ministry of Defence has ordered its first consignment of Celox Rapid, having made the decision to switch to this latest generation of life-saving haemostat at the end of last year. . The MoD decision comes following extensive selection process that identified Celox Rapid as the most effective and fastest acting haemostatic gauze available to stop life-threatening bleeding injuries. 

Blood loss is the largest cause of preventable death both on the battlefield and in civilian trauma, and as a result, haemostats are increasingly being carried by military medics and civilian emergency responders alike. Celox Rapid, manufactured in the UK, is the global leader in this technology, which is based on Chitosan, and can stop life threatening arterial bleeding in under 60 seconds.

“Everyone in the Celox Trauma team is delighted that Celox Rapid has been selected by the UK MoD. Celox has been carried by front line forces for over 10 years, and this decision to move to ‘Rapid’ means significantly faster treatment times under fire, increasing survivability for both the casualty and medic alike.”
Geraint Lloyd, Business Manager, Medtrade Products Ltd.

 

The next step for the UK’s armed forces in their fight to control bleeding injuries on the battlefield

Since 2006 when Celox granules were first introduced, Celox trauma products have been used to save the lives of soldiers and civilians alike. In 2008, the third generation haemostat Celox Gauze became the UK MoD product of choice and was used to save lives in the recent conflicts in Iraq and Afghanistan. Now Celox Rapid Gauze takes over as product of choice and will be used on the front line by all branches of the armed forces. 

Celox vs. Combat Gauze

Celox vs. Quikclot Combat Gauze. Treatment time is the combined time of wound packing and compression time.

Time is critical when treating severe injuries in the field and saving time increases the chance of survival for the casualty in an emergency or hostile situation.  To be effective in real use, haemostatic dressings need to work fast.

The current generation of haemostatic agents need at least 3 minutes of compression to work.  Celox RAPID Gauze removes the delay by speeding up packing time10 and reducing compression time to just 60 seconds while using the proven haemostat technology of Celox. In recent tests Celox Rapid demonstrated successfully in laboratory coagulopathic bleeding[22]

Tried and Tested

How is Celox Rapid used

To stop the bleed, Celox Rapid is used in a step-wise approach to haemorrhage control.

Independent testing9 on Celox RAPID has shown the product works on lethal injuries  and significantly reduces blood loss compared to Quikclot Gauze*. As well as reducing treatment time and blood loss, a model of tactical evacuation showed that the Celox RAPID Gauze stayed in place during transport with no re-bleeding10.

 

For further information on Celox Rapid, please Click here.

Media Contact:
James Lindop
Product Manager
email: james.lindop@medtrade.co.uk

Used By Professionals Everywhere

MilitaryCelox forMilitaryLaw EnforcementCelox forLaw EnforcementHospitalsCelox forHospitalsEmergency Medical ServicesCelox forEmergency Medical ServicesRemote MedicineCelox forRemote MedicinePublic AccessCelox forPublic Access

Join Our Mailing List



You can also sign up for specific lists:

Any information you give us will be stored safely and only used in line with our Privacy Policy

Contact Us

Medtrade Products Ltd
Electra House, Crewe Business Park, Crewe, UK, CW1 6GL

Social

© Medtrade Products Ltd 2018

This website uses Cookies to improve your browsing experience. View Cookies Policy

I'm fine with this